Skip to content
Screener

IDEAYA Biosciences, Inc. IDYA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
$15.42M-9.3%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$34.65M-12.7%
Immunome logo
ImmunomeIMNM
$2.83M-32.1%
Erasca, Inc. logo
Erasca, Inc.ERAS
$28.27M-10.3%
Nuvation Bio logo
Nuvation BioNUVB
$3.24M-30.2%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
10.2%0.0pp

Other financials

Income statement

See full
Revenue$6.6M
Operating income-$108.5M-28.6%
Net income-$98.5M-36.5%
EPS (diluted)-$1.11-35.4%

Balance sheet

See full
Cash & equivalents$157.5M+21.2%
Total debt$28.6M+10.1%
Total equity$937.3M-8.5%
Total assets$1.0B-6.4%

Cash flow

See full
Operating cash flow-$75.2M-24.6%
CapEx$967.0K-27.3%
Free cash flow-$76.1M-23.5%

Valuation

See full
Market cap$3.49B+68.5%
Enterprise value$3.36B+69.4%
P/S15×+10.3×

Profitability

See full
Operating margin-4,671.1%-5,434pp
Net margin-3,921.1%-4,562pp
FCF margin-3,592%-4,290pp

Returns & leverage

See full
Return on equity-14.3%-5.0pp
Debt / equity0.0×
Current ratio10.7×-3.2×

Where this comes from

Reported directly by IDEAYA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:05 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206357
Line itemMarch 31, 2026December 31, 2025
Restricted cash1,2811,015
Long-term marketable securities301,713410,297
Property and equipment, net8,6348,217
Right-of-use assets22,61323,068
Total assets$1,030,348$1,109,324
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable$20,736$17,584

Item 1. Financial Statements (UNAUDITED).

FAQ

What is IDEAYA Biosciences, Inc.'s operating lease ROU assets?
IDEAYA Biosciences, Inc. (IDYA) reported operating lease ROU assets of $22.61M in Q1 2026.
How has IDEAYA Biosciences, Inc.'s operating lease ROU assets changed year-over-year?
IDEAYA Biosciences, Inc.'s operating lease ROU assets decreased by 7.4% year-over-year, from $24.43M to $22.61M.
What is the long-term trend for IDEAYA Biosciences, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), IDEAYA Biosciences, Inc.'s operating lease ROU assets has grown at a 34.7% compound annual growth rate (CAGR), from $5.21M to $23.07M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about IDEAYA Biosciences, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude